06.06.2018
RHÖN-KLINIKUM AG DE0007042301
DGAP-News: RHÖN-KLINIKUM AG: Annual General Meeting of RHÖN-KLINIKUM AG in Bad Neustadt/Saale for the First Time
DGAP-News: RHÖN-KLINIKUM AG / Key word(s): AGM/EGM/AGM/EGM
RHÖN-KLINIKUM AG: Annual General Meeting of RHÖN-KLINIKUM AG in Bad
Neustadt/Saale for the First Time
06.06.2018 / 16:45
The issuer is solely responsible for the content of this announcement.
---------------------------------------------------------------------------
Corporate News
Bad Neustadt / Saale | 6th June 2018
Annual General Meeting of RHÖN-KLINIKUM AG in Bad Neustadt / Saale for the
First Time
- Consent to dividend proposal and appropriation of net distributable profit
- Formal approval of actions of Stephan Holzinger, Prof. Dr. Bernd Griewing
and
Dr. Martin Siebert
- Formal approval of actions of Supervisory Board members
As specified in the agenda the 30th ordinary Annual General Meeting of
RHÖN-KLINIKUM AG which took place for the first time in Bad Neustadt/Saale
where the Company is registered has made the following decisions:
The sum of approx. Euro 14.7 million from the 2017 net distributable profit
will be used for the distribution of a dividend of Euro 0.22 per non-par
share; this corresponds to a dividend payout ratio of approx. 40 percent.
With this ratio RHÖN-KLINIKUM AG safeguards its medium-term ability to make
investments yet also allows its shareholders to participate in the future
success of the Company. The actions of the members of the Board of
Management, Stephan Holzinger (98.31 percent), Prof. Dr. Bernd Griewing
(98.31 percent), Martin Menger (99.99 percent) and Dr. Martin Siebert (99.99
percent) who were in office in financial year 2017, and the members of the
Supervisory Board who were in office in 2017 have been formally approved.
The executive board member Jens-Peter Neumann who was in office in financial
year 2016 and 2017, on the other hand, has not been formally approved.
CEO Stephan Holzinger confirmed the outlook for the current financial year
as well as the operative and strategic challenges. For 2018 the Company
expects revenues in the amount of Euro 1.24 billion plus/minus 5 percent. "A
continuing burden on us as a facility offering maximum medical care remains
regulatory legislation such as lower remuneration for services with high
material costs (especially cardiological services) or the discount for lower
overheads on additional services," Holzinger stated.
For 2018 the hospital group expects a much higher amount for earnings before
interest, taxes, depreciation and amortization (EBITDA) of between Euro
117.5 million and Euro 127.5 million in comparison with 2017 - positively
influenced by the agreement with the university hospital in Giessen and
Marburg (UKGM) regarding separate accounting as well as other effects.
Corporate Strength and Strategic Direction
Holzinger stated that the strategic focus is being placed on the further
development and implementation of the RHÖN campus concept, the comprehensive
digital transformation of the Company in the areas of medical care, nursing
and administration as well as continuous attention to operative
improvements.
With a view to improving economic efficiency Holzinger explained: "The
package of measures which was initiated last year throughout the corporate
group in order to optimise the financial figures continues to take effect.
One positive example is the project to safeguard revenues by reducing
avoidable losses arising from objections by the Medical Review Board of the
Statutory Health Insurance Funds (Medizinischer Dienst der
Krankenversicherungen - MDK). To this end we have continued to improve our
existing control and reporting system and implemented a group-wide (further)
education programme as well as made the decision to use intelligent software
for testing purposes."
Further potential was also discovered in our project for managing materials:
maintenance agreements were analysed, purchasing synergies were set up
between different hospitals and the use of material was further improved
while preserving the highest quality standards. "This shows that it is
possible to achieve both excellent medical care and economic efficiency when
all the parties involved work well together. In view of the pressure of
costs it is no longer self-evident that we can encourage and invest
extensively in innovations throughout the corporate group," Holzinger
stated.
The CEO emphasized the strategic direction of the Company in his speech. It
is possible to detect definite potential for improvement in the healthcare
system by managing medical care more efficiently for the benefit of the
patient. This is at the heart of the RHÖN campus strategy. "Our campus
stands for forward-looking excellent medical care particularly in rural
areas, breaking down the previous boundaries in both out-patient and
in-patient care. 2018 will be a special year for our Company: we shall
complete our flagship project, the new campus in Bad Neustadt, at the end of
the year, confirming yet again that we are not afraid to be the first to
tread new paths," Holzinger stated.
RHÖN-KLINIKUM AG is putting its new campus concept into practice in an ideal
manner for the first time at its headquarters. By the end of 2018 there will
be new buildings constructed on the hospital campus designed as centres for
in-patient and out-patient medical care setting innovative and revolutionary
standards not only in hospital architecture but also in both out-patient and
in-patient medical care with state-of-the-art medical equipment. Most of the
clinics will then be under one roof allowing ever closer links between the
different therapeutic approaches in healthcare. The new integrated building
complex will shorten distances between medical specialists reflecting the
overall process of patient care in a modular system - encompassing both
prevention and out-patient and in-patient acute and rehab care as well as
broader healthcare services.
The Company is also pushing on with its digitalization strategy in order to
be able to offer faster diagnoses and treatments along with improved medical
history records, by using state-of-the-art clinical information systems,
electronic patient records and new digital instruments. "This gives our
physicians and nurses a first-class system to analyse patient data
thoroughly yet quickly. We are also using innovative telemedicine to link
our group hospitals with other hospitals, local GPs and specialist
physicians, rescue services and other out-patient facilities, both locally
and further afield. This makes our healthcare even safer and faster and it
also offers our physicians and nurses noticeable alleviation in their
workload with the use of our medical cockpit, for example," Holzinger
emphasized.
Financial Figures for 2017 and 1st Quarter 2018
A total of 836,387 patients were treated at the five sites of the Company in
2017 (2016: 813,747). Revenues stood at Euro 1.21 billion and rose by
approx. 3 percent when compared with the previous year (2016: Euro 1.18
billion). The figure for earnings before interest, taxes, depreciation and
amortisation (EBITDA) of Euro 97.8 million is lower when compared with the
previous year (2016: Euro 156.9 million): the drop amounts to 14.9 percent
following adjustments for subsequent transaction effects of Euro 42 million
from dissolving provisions in 2016 in connection with the Helios
transaction. The net consolidated profit amounted to Euro 36.7 million
(2016: Euro 58.6 million): this results from the transaction effects and an
adjustment in the opposite direction in the amount of Euro 35.5 million in
connection with the Marburg particle therapy centre from financial year
2016.
In the first quarter of financial year 2018 RHÖN-KLINIKUM AG was able to
increase its net distributable profit by almost one quarter in comparison
with the same period in the previous year; EBITDA and revenues also rose
significantly: 216,602 patients (+ 2.1 percent) were treated in the group
hospitals, revenues stood at Euro 311.7 million (+3.9 percent), earnings
before interest, taxes, depreciation and amortisation (EBITDA) were at Euro
27.6 million (+8.2 percent) and the resulting net distributable profit
reached Euro 10.4 million (+23.8 percent). This rise in the net
distributable profit for the quarter does not yet include the positive
effects from the successful agreement on separate accounting with the
Federal State of Hesse and the two university hospitals in Giessen and
Marburg: the final precondition for the agreement which was concluded in
2017 to come into force, validation of the agreement by an auditor, will
probably take place in the third quarter of 2018.
--------------------------------------------------------------------------------------------
RHÖN‐KLINIKUM AG is one of the largest healthcare providers in Germany. The
hospital group offers excellent medical care with a direct link to
universities and research institutes. More than 830,000 patients are treated
every year at the five group hospitals located in Bad Berka, Bad Neustadt,
Frankfurt (Oder), Giessen and Marburg where approx. 16,700 employees work.
With the RHÖN campus concept the Company is currently implementing a new and
forward-looking project which raises fully comprehensive healthcare in rural
areas to a new level of excellence and is geared to the growing needs of
patients. www.rhoen-klinikum-ag.com
Contact Person:
RHÖN-KLINIKUM AG
Head of Investor Relations | Mr. Julian Schmitt
Telephone: +49 9771 65-1536 | E-Mail: [email protected]
Contact:
Corporate Communications
RHÖN-KLINIKUM AG
Schlossplatz 1
97616 Bad Neustadt a. d. Saale
T. +49 9771 65-1327
---------------------------------------------------------------------------
06.06.2018 Dissemination of a Corporate News, transmitted by DGAP - a
service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.
The DGAP Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Archive at www.dgap.de
---------------------------------------------------------------------------
Language: English
Company: RHÖN-KLINIKUM AG
Salzburger Leite 1
97616 Bad Neustadt a.d.Saale
Germany
Phone: +49 (0)9771 - 65-0
Fax: +49 (0)9771 - 97 467
E-mail: [email protected]
Internet: www.rhoen-klinikum-ag.com
ISIN: DE0007042301
WKN: 704230
Indices: SDAX
Listed: Regulated Market in Frankfurt (Prime Standard), Munich;
Regulated Unofficial Market in Berlin, Dusseldorf,
Hamburg, Stuttgart, Tradegate Exchange
End of News DGAP News Service
---------------------------------------------------------------------------
693127 06.06.2018
|
Weitere Ad-hoc und Unternehmensrelevante Mitteilungen zu
RHÖN-KLINIKUM AG ISIN: DE0007042301 können Sie bei EQS abrufen
Pflegeeinrichtungen , 704230 , RHK , XETR:RHK